Octreotide in the management of bowel obstruction in terminal ovarian cancer.

Mangili, G

Octreotide in the management of bowel obstruction in terminal ovarian cancer. [electronic resource] - Gynecologic oncology Jun 1996 - 345-8 p. digital

Publication Type: Clinical Trial; Journal Article

0090-8258

10.1006/gyno.1996.0154 doi


Adolescent
Adult
Aged
Antineoplastic Agents, Hormonal--therapeutic use
Carcinoma--complications
Female
Gastrointestinal Agents--therapeutic use
Humans
Intestinal Obstruction--complications
Intubation, Gastrointestinal
Middle Aged
Octreotide--therapeutic use
Ovarian Neoplasms--complications
Palliative Care
Treatment Outcome
Vomiting--etiology